ClinicalTrials.gg

Streptococcal Infections clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 147 studies for Streptococcal Infections across more than 10 countries. 14 are recruiting or about to start. 117 of them are mainly about Streptococcal Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13. Counting its 5 narrower conditions too, such as Pneumococcal Infections: 587 studies, 86 open.

Status

Completed
109
Recruiting
10
Withdrawn
9
Active, not recruiting
8
Not yet recruiting
4
Terminated
3

Phase

Phase 3
44
Phase 2
29
Phase 1
18
Phase 4
5
Early Phase 1
1

Where

United States
24
Poland
10
France
9
Spain
8
Germany
8
South Africa
7

Who develops what

Add Streptococcal Infections to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 6 programs from 3 companies, 5 with this as their studies’ main aim; 1 with a live phase 3 study; 1 primary completion in the next 12 months. Compare GlaxoSmithKline and CanSino Biologics here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
13-valent pneumococcal vaccineRecent, limitedPhase 4 trial recorded
Evidence
  • NCT07017777 · CanSino Biologics Inc. · Phase 3 · live · comparator · “Prevnar 13” · registered Jun 2025
  • NCT04841369 · CanSino Biologics Inc. · Phase 3 · comparator · “13-Valent Pneumococcal Polysaccharide Conjugate Vaccine” · registered Apr 2021
  • NCT01616459 · GlaxoSmithKline · Phase 2 · comparator · “Prevnar 13™” · registered Jun 2012
  • NCT01545375 · GlaxoSmithKline · Phase 2 · background · “Prevnar 13®” · registered Mar 2012
  • NCT01262872 · GlaxoSmithKline · Phase 2 · comparator · “Prevnar13™” · registered Dec 2010
Pfizer73% of its industry studies11 study

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 6 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (1)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • 15 Feb 2027 est.13-valent pneumococcal vaccine · CanSino Biologics Inc. · Phase 3 named, not the main aimNCT07017777 A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks) — primary endpoint: Proportion of participants achieving serotype-specific IgG antibody concentrations ≥ 0.35 µg/mL · 600 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Streptococcal Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Coming up

5studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5, phase 3 first

Who these studies take

Of the 10 Streptococcal Infections studies recruiting now, 6 (60%) set no upper age limit and 3 (30%) stop at 75 or younger. 4 (40%) take children under 18. 1 (10%) are for women only and 0 (0%) for men only; 2 (20%) take healthy volunteers.

Recruiting studies that take each age, of 10
AgeWomenMen
103 (30%)2 (20%)
189 (90%)8 (80%)
308 (80%)7 (70%)
408 (80%)7 (70%)
507 (70%)6 (60%)
657 (70%)6 (60%)
757 (70%)6 (60%)
856 (60%)5 (50%)

Across all 147 studies, recruiting or not: 71% stop at 75 or younger and 71% at 65; 64% take children; 20% are for women only and 1% for men only; 67% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Streptococcal Infections studies take

Of 29 phase 3 interventional studies under Streptococcal Infections, half reached primary completion within 10 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 213 mo9–25 · 12 studies——
Phase 310 mo8–16 · 29 studies9 mo7–13 · 28 studies—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 147. Browse all 147 → or search them.